# Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

> **NCT00718172** · PHASE1 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 81 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **PROCEDURE:** Liver Biopsy
- **DRUG:** Peginterferon & Ribavirin for Hepatitis C
- **DRUG:** Pre-treatment Ribavirin

## Key facts

- **NCT ID:** NCT00718172
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-11
- **Primary completion:** —
- **Final completion:** 2014-08-19
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718172, "Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00718172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*